Since 1996, Zynex Medical has been a leading provider of relief for patients with functional disability through the creation, distribution and marketing of the highest quality electrotherapy products available today. Zynex Medical continually strives to uphold its mission to improve the quality of life of patients suffering from debilitating pain or illness by providing the highest technology and service standards in the electrotherapy industry. Utilizing various methods of non-invasive muscle stimulation and state-of-the-art electromyography technology, Interferential Current (IFC) and Transcutaneous Electrical NerveStimulation (TENS), Zynex Medical offers patients a new lease on life through increased mobility and independence.
This link goes directly to ZYNX's Products expanding on their product line
The Zynex Medical product line demonstrates the ideology the company strives to uphold: a commitment to quality, a passion for innovation and a dedication to the health of the patients they serve. Included among the impressive line of non-invasive electrotherapy products offered are:
- TENS units
- Interferential Current (IFC)
- Electronic Muscle Stimulation (EMS)
- Incontinence Therapy
- Stroke Rehabiliation
- Spinal Cord Injury Rehabilitation
- Placement Charts
Stroke Recovery Systems
Current statistics indicate that there are over 4 million people in the United States who have survived a stroke or brain attack and are living with the after-effects (National Stroke Association). With the rehabilitation efforts of Stroke Recovery Systems (a division of Zynex Medical), however, there remains hope for increased mobility, functionality and quality of life for the patients living with the incapacitating consequences of stroke.
Through rehabilitation, an individual who has experienced a stroke is empowered to reach the highest possible level of independence and to be as productive as possible. To help patients reach this goal, Zynex Medical has developed the NeuroMove technique, which is designed to increase functionality among stroke victims by teaching the healthy parts of the brain to compensate for the injured areas. With this technique, the NeuroMove offers new hope to patients whose functional development may have slowed or ceased by providing state-of-the-art, barrier-breaking tools in the battle toward recovery.
The NeuroMove has achieved success in approximately 90% of cases, with patients both achieving and maintaining significant functional improvement. The Neuro move is cleared by the FDA specifically for stroke rehab and has been proven effective in many clinical studies. Many stroke and spinal cord injured patients in the US have experienced dramatic results with this device used in the home.
SIZE SALES FORCE HISTORY
HISTORICAL FINANCIAL INFORMATION
|Quarter ||Revenue ||Diluted EPS |
|Q3'08 ||$3,502,994 ||$0.021 |
|Q2'08 ||$5,047,635 ||$0.061 |
|Q1'08 ||$3,741,028 ||$0.041 |
|Q4'07 ||$3,101,868 ||$0.032 |
|Q3'07 ||$2,104,446 ||$0.021 |
|Q2'07 ||$1,505,207 ||$0.013 |
|Q1'07 ||$1,336,731 ||$0.008 |
|Q4'06 ||$747,071 ||-$0.009 |
|Q3'06 ||$743,787 ||$0.001 |
|Q2'06 ||$560,860 ||-$0.004 |
|Q1'06 ||$505,091 ||-$0.001 |
This link goes dierctly to ZYNX's Recent News
FINANCIALS and SEC FILINGS
This link goes direcly to ZYNX's SEC Filings
CONTACT INFO, MANAGEMENT TEAM, & IR